REVIEW OF STUDIES ON MODE OF ACTION OF CLOFIBRATE AND BETABENZALBUTYRATE

被引：30

作者：

FALLON, HJ

ADAMS, LL

LAMB, RG

机构：

来源：

LIPIDS | 1972年 / 7卷 / 02期

关键词：

D O I：

10.1007/BF02532596

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：106 / +

页数：1

共 35 条

[1] INHIBITION OF HEPATIC TRIGLYCERIDE FORMATION BY CLOFIBRATE [J].

ADAMS, LL ;

WEBB, WW ;

FALLON, HJ .

JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (11) :2339-&

[2]

AVOY DR, 1965, J LIPID RES, V6, P369

[3] STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE) [J].

AZARNOFF, DL ;

TUCKER, DR ;

BARR, GA .

METABOLISM, 1965, 14 (09) :959-&

[4]

BANET AM, 1966, BRIT J PHARM, V26, P363

[5]

BEST MM, 1964, J LAB CLIN MED, V64, P634

[6] REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE ( CPIB ) [J].

BEST, MM ;

DUNCAN, CH .

AMERICAN JOURNAL OF CARDIOLOGY, 1965, 15 (02) :230-&

[7]

BIERMAN EL, IN PRESS

[8]

CANONICA L, 1961, DRUGS AFFECTING LIPI, P328

[9] EFFECTS OF ETHYL-P-CHLOROPHENOXYISOBUTYRATE CLOFIBRATE ON PLASMA AND RED BLOOD CELL FREE FATTY ACIDS OF RAT [J].

CENEDELLA, RJ ;

JARRELL, JJ ;

SAXE, LH .

JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1968, 8 (06) :903-+

[10]

DVOBODA DJ, 1971, FED PROC, V30, P841

← 1 2 3 4 →